Resolution CM/Res(2020)3 on the implementation of pharmaceutical care for the benefit of patients and health services
Citation:
Rapporteur, Resolution CM/Res(2020)3 on the implementation of pharmaceutical care for the benefit of patients and health services, Strasbourg, Council of Europe, March, 2020Download Item:

Author's Homepage:
http://people.tcd.ie/mhenmanDescription:
PUBLISHEDThe resolution will provide health authorities across Europe with guidance and recommendations supporting the promotion and implementation of pharmaceutical care as a quality-enhancing element in healthcare systems at regional and national level. Also, healthcare professionals and associations will have a legal basis for the implementation of pharmaceutical care and related working methods in their daily activities. The primary aim of all healthcare professionals involved in the medication process should be to achieve the best possible improvement in quality of life for the patient. However, the potential benefits of medications are sometimes not fully realised (e.g. due to lack of medication adherence) or, even worse, inappropriate use of medicines can lead to increased morbidity or even mortality.Pharmaceutical care directly and comprehensively addresses the medication needs of patients and, in doing so, contributes to the overall efforts of healthcare professionals in providing care that is centred around the patient, optimising medication use and promoting rational use of resources.
Strasbourg
Author: Henman, Martin
Publisher:
Council of EuropeType of material:
ReportAvailability:
Full text availableKeywords:
Health care, Health services, PharmacySubject (TCD):
Inclusive Society , International Development , International Integration , Clinical Pharmacy , EQUITY , Electronic Healthcare Records , Global Health , HEALTH AUTHORITIES , HEALTH CARE ORGANIZATION , HEALTH CARE UTILIZATION , HEALTH ECONOMICS , HEALTH INDICATORS , HEALTH PROFESSIONALS , HEALTH PROMOTION , HEALTH SERVICES RESEARCH , HEALTH-CARE PROVIDERS , HEALTHCARE USE , Health Care Policy , Health Care Reform , Health Planning/Policy , Health Service Development , Health Service Utilisation , Health Service models , Health Services Delivery , Health Systems Integration , Health and Social Care Policy , Health care and health services , Health inequality , Health interventions and innovations , Health interventions and innovations ; Health outcomes;Health Informatics , Health outcomes , Health policy , Health-related Quality of Life , Healthcare Innovation , Healthcare Policy Implications , Healthcare Quality Improvement , Healthcare Reform , Healthcare Risk Management , Hospital Pharmacy , Inclusive global health (especially disability and ethnicity , Integrated Community Healthcare , Leadership in Healthcare , MEDICATION , MEDICATION COMPLIANCE , MEDICATION ERRORS , MEDICATION MANAGEMENT , MEDICATION REVIEW , MEDICATION USE , MEDICATIONS , MEDICINES MANAGEMENT , Medication Reconciliation , Medication burden , Medication safety , Medicines , Non-prescription Medicines , PHARMACEUTICAL CARE , PHARMACY PRACTICE , POLYPHARMACY , Pharmaceutical Policy , Pharmacists role in health education and promotion , Pharmacy , Pharmacy Education , Pharmacy Policy , Practice of pharmacy , Prescription Medicines , Public Health , Public Policy , QUALITY USE OF MEDICINES , Self-Medication , Strengthening health systems , community pharmacy , health care and health services , health literacy , health outcomes research , health systems and policy , healthcare services , pharmacy services , population healthHandle:
http://hdl.handle.net/2262/92711Source URI:
https://rm.coe.int/09000016809cdf26Licences: